The market expects Elevance Health (ELV) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook ...

Elevance Health (ELV) shares ended the last trading session 6.1% higher at $538.48. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

In its upcoming report, Elevance Health (ELV) is predicted by Wall Street analysts to post quarterly earnings of $6.18 per share, reflecting a decline of 30.1% compared to the same period last year.

Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings ...

Heartland Advisors, an investment management company, released its first-quarter 2026 investor letter for the “Heartland ...

We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other top falling ...

Elevance Health Inc. (NYSE:ELV) is one of the best value stocks to buy right now. On June 23, Elevance Health announced ...

Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn’t enough to erase its worst day since ...

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors ...